Both ERα and progesterone receptor (PR) expression were strongly associated with improved survival for endometrioid ovarian carcinoma, while PR (but not ERα) was associated with favorable outcomes in HGSOC [30]. Here, PGR is linked to ovarian endometrioid carcinoma.